Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dymphna

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
BMC Cancer|June 23, 2016
Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 studyJohn Bridgewater, Andre Lopes, Sandra Beare, et al.
BMC Cancer|February 26, 2016
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 studyJohn Bridgewater, Andre Lopes, Sandra Beare, et al.
Frontiers in Bioscience (Landmark Edition)|January 29, 2022
Canonical WNT pathway inhibition reduces ATP synthesis rates in glioblastoma stem cellsDymphna Margriet Ouwens, Michael Hewera, Guanzhang Li, et al.
Plos One|February 28, 2020
A systematic review and meta-analysis on the effectiveness of an invasive strategy compared to a conservative approach in patients > 65 years old with non-ST elevation acute coronary syndromeJoan Dymphna P Reaño, Louie Alfred B Shiu, Karen V Miralles, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
BMC Cancer|June 23, 2016
Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 studyJohn Bridgewater, Andre Lopes, Sandra Beare, et al.
BMC Cancer|February 26, 2016
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 studyJohn Bridgewater, Andre Lopes, Sandra Beare, et al.
Frontiers in Bioscience (Landmark Edition)|January 29, 2022
Canonical WNT pathway inhibition reduces ATP synthesis rates in glioblastoma stem cellsDymphna Margriet Ouwens, Michael Hewera, Guanzhang Li, et al.
Plos One|February 28, 2020
A systematic review and meta-analysis on the effectiveness of an invasive strategy compared to a conservative approach in patients > 65 years old with non-ST elevation acute coronary syndromeJoan Dymphna P Reaño, Louie Alfred B Shiu, Karen V Miralles, et al.
Pageof 3